Literature DB >> 6511866

Candida pseudotropicalis fungemia and invasive disease in an immunocompromised patient.

M A Morgan, C J Wilkowske, G D Roberts.   

Abstract

A case of Candida pseudotropicalis fungemia and invasive disease in an immunocompromised patient is reported. Multiple blood cultures taken over a 2-week period were positive, and histopathological slides of postmortem spleen and kidney tissue showed tissue invasion by the organism. The source of the yeast infection was determined to be the urinary tract. This is the first report of C. pseudotropicalis fungemia documented by culture.

Entities:  

Mesh：

Year:  1984        PMID： 6511866      PMCID： PMC271498          DOI： 10.1128/jcm.20.5.1006-1007.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  THE YEAST FLORA OF THE ANOGENITAL REGION IN DIABETIC GIRLS.

Authors:  C E SONCK; O SOMERSALO
Journal:  Arch Dermatol       Date:  1963-12

2.  [Acute, generalized mycosis; sepsis caused by candida pseudotropicalis].

Authors:  P SKOBEL; D JORKE; G SCHABINSKI
Journal:  Munch Med Wochenschr       Date:  1955-02-18

3.  Yeasts of human origin.

Authors:  A STENDERUP; G T PEDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1962

4.  [Fungus diseases of internal organs as a result of antibiotic therapy with special reference to the respiratory tract].

Authors:  T WEGMANN
Journal:  Antibiot Chemother       Date:  1954

5.  Natural history of Candida species and yeasts in the oral cavities of infants.

Authors:  C Russell; K M Lay
Journal:  Arch Oral Biol       Date:  1973-08       Impact factor: 2.633

6.  Oral Candida and long-term tetracycline therapy.

Authors:  A J McKendrick; M I Wilson; D M Main
Journal:  Arch Oral Biol       Date:  1967-02       Impact factor: 2.633

7.  Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981).

Authors:  J Bille; L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

8.  Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host.

Authors:  J C Parker; J J McCloskey; K A Knauer
Journal:  Am J Clin Pathol       Date:  1976-06       Impact factor: 2.493

9.  An epidemiologic study of yeasts in elderly denture wearers.

Authors:  E Budtz-Jörgensen; A Stenderup; M Grabowski
Journal:  Community Dent Oral Epidemiol       Date:  1975-05       Impact factor: 3.383
  9 in total
  11 in total

1.  Huge fungal perinephric abscess masquerading as malignancy.

Authors:  Sharath P Madhyastha; Raviraja V Acharya; Barnini Banerjee; Koteshwara Prakashini
Journal:  BMJ Case Rep       Date:  2018-12-31

2.  Presumptive identification of Candida kefyr on levine formulation of eosin methylene blue agar.

Authors:  Erik L Munson; Dennis R Troy; Joanne K Weber; Shawn A Messer; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 3.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Detection of Candida sp. mannan antigen by indirect ELISA-inhibition. In vitro crossed reactivity among mannans obtained from C. albicans A, C. albicans B, and C. tropicalis.

Authors:  J Garcia-de-Lomas; C Morales; M A Grau; A Mir
Journal:  Mycopathologia       Date:  1988-06       Impact factor: 2.574

Review 5.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 6.  Uncommon yeastlike zoopathogens and commercial systems for their identification.

Authors:  G A Land; I F Salkin
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

7.  In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.

Authors:  J M Hernández Molina; J Llosá; A Martinez Brocal; A Ventosa
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

8.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Epidemiology of Candida kefyr in patients with hematologic malignancies.

Authors:  Simon F Dufresne; Kieren A Marr; Emily Sydnor; Janet F Staab; Judith E Karp; Kit Lu; Sean X Zhang; Christian Lavallée; Trish M Perl; Dionysios Neofytos
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

10.  Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR.

Authors:  Hassan O J Morad; Anna-Maria Wild; Stefan Wiehr; Genna Davies; Andreas Maurer; Bernd J Pichler; Christopher R Thornton
Journal:  Front Microbiol       Date:  2018-08-23       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.